Effect of AI(Artificial Intelligence)-Based Storytelling Video on Anxiety and Fear During Skin Prick Test in Children
AI-Based Video-Mediated Cognitive Preparation in Skin Prick Testing: A Prospective, Randomized Controlled Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
This study evaluates the effectiveness of an AI-generated therapeutic storytelling video on pre-procedural anxiety and fear levels in children aged 4 to 10 years undergoing their first Skin Prick Test (SPT). The study aims to determine if watching a cognitive preparation video at home prior to the appointment reduces anxiety compared to standard care. Participants will be randomized into two groups: an intervention group watching the AI-generated video and a control group receiving standard clinic care
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable anxiety
Started Mar 2026
Shorter than P25 for not_applicable anxiety
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2026
CompletedFirst Posted
Study publicly available on registry
March 6, 2026
CompletedStudy Start
First participant enrolled
March 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 15, 2026
March 18, 2026
March 1, 2026
4 months
March 2, 2026
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Baseline Anxiety Level
Assessed using the Spence Preschool Anxiety Scale (for ages 4-6) or Spence Children's Anxiety Scale (for ages 7-10). These validated scales measure general anxiety symptoms. Higher scores indicate higher levels of anxiety.
Baseline
Acute Procedural Fear Level
Assessed using the Children's Fear Scale (CFS). This scale consists of five facial expressions representing a range from neutral (0) to extreme fear (4). Higher scores indicate higher levels of acute fear.
Immediately post-procedure
Secondary Outcomes (2)
Behavioral Distress During Procedure
Periprocedural
Self-Reported Procedural Pain
Immediately post-procedure
Study Arms (2)
AI-Video Intervention Group
EXPERIMENTALParticipants in this group will watch an AI-generated therapeutic storytelling video about the Skin Prick Test procedure at home, twice before their clinical appointment
Standard Care Group
ACTIVE COMPARATORParticipants in this group will receive standard routine verbal information and standard clinic care prior to the procedure, without any digital preparatory intervention.
Interventions
A customized, AI-assisted animated story video featuring child-friendly characters (Lilly and Doctor Sunny) explaining the Skin Prick Test procedure. It is watched at home the evening the appointment is made and the night before the procedure to provide cognitive preparation.
Routine verbal explanation of the procedure provided by the clinic staff.
Eligibility Criteria
You may qualify if:
- Children aged between 4 and 10 years (from 4th birthday to 11th birthday).
- Children undergoing a Skin Prick Test (SPT) for the first time.
- Presence of suspected Allergic Rhinitis and/or Asthma.
- Cognitive ability to understand Turkish, follow the video story, and interpret visual assessment scales.
- Parents with internet access to view the digital content.
- Obtained parental informed consent and child assent (for ages 7 and above)
You may not qualify if:
- Previous experience with Skin Prick Testing or a history of frequent medical procedures (e.g., frequent blood draws, surgeries) due to chronic illness.
- Diagnosed with Autism Spectrum Disorder, severe ADHD(attention deficit hyperactivity disorder), intellectual disability, or severe psychiatric conditions preventing cooperation.
- Significant visual or hearing impairments that prevent engagement with the video content.
- Use of anxiolytics, sedatives, or medications affecting cognitive functions within the last 24 hours.
- Chronic health problems (e.g., malignancy, immunodeficiency) that may elevate baseline anxiety levels.
- Patients undergoing SPT for suspected Food Allergy, Drug Allergy, or Bee Venom Allergy.
- For the intervention group: Failure to watch the video or answering the three "validation questions" incorrectly on the procedure day.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Sciences University Antalya Training and Research Hospital
Antalya, 07030, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- "The administering nurse who performs the Skin Prick Test (SPT) and acts as the outcome assessor will be blinded to the participants' group assignment. The nurse will not know whether the child watched the AI-generated cognitive preparation video prior to the procedure or is in the standard care control group. This ensures that the observational scoring of the child's behavioral distress during the procedure is unbiased."
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2026
First Posted
March 6, 2026
Study Start
March 15, 2026
Primary Completion (Estimated)
July 15, 2026
Study Completion (Estimated)
September 15, 2026
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Data and supporting information will be available beginning 6 months after the publication of the primary manuscript and ending 5 years following article publication.
- Access Criteria
- Access to the IPD and supporting documents will be granted to researchers who provide a methodologically sound proposal for secondary analyses or meta-analyses. Requests should be directed to the central contact person (Dr. Enes Onkun) via email. Upon approval of the proposal, data will be shared securely via an encrypted digital transfer method.
De-identified individual participant data (IPD) that underlie the results reported in the future published article will be shared. This includes demographic characteristics, anxiety scale scores, fear scale scores, behavioral distress scores, and pain scores, strictly after removing any personally identifiable information